Insulin pump therapy is associated with improved glycaemic control and reduced hypoglycaemia compared with multiple daily insulin injections (7), and CGM is associated with improved glucose control and reduced hypoglycaemia compared to fingerstick capillary glucose monitoring (8, 9, 10, 11). The gene discussed is INS; the disease is Hypoglycemia.